HAIKOU, China, July 7, 2024 /PRNewswire/ — A report from Hainan International Media Center (HIMC):
On July 4, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich, Switzerland.
From July 4-6, a delegation from China’s southern Hainan Province held Hainan Free Trade Port (FTP) related promotion and exchange activities in Switzerland, cementing cooperation in the fields of medical health, education, and high-end shopping & consumption.
During their time in Switzerland, the Hainan delegation held discussions and research meetings with numerous important companies and institutions, including Merck, Richemont, Roche Diagnostics, EHL Hospitality Business School, Switzerland Global Enterprise, the World Trade Organization, and the World Intellectual Property Organization.
Inviting Swiss counterparts to leverage the FTP’s preferential policies, Hainan is specifically promoting cooperation in the fields of medical health, independent school running, and intellectual property protection. Hainan also made a point of expressing their warm welcome to Swiss enterprises to take part in the 5th China International Consumer Products Expo in April, 2025.
Co-organized by Hainan’s provincial government and the Switzerland Global Enterprise, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich on July 4. The event was well-received, with nearly 50 representatives from well-known Swiss companies and industry associations (including the Swiss Medical Technology Association, the the Swiss Scientific and Industrial Pharmaceutical Association, Novartis, Nestlé Health Science, Sonova, Similasan, Alcon, and IBSA) in attendance.
At the meeting, the Swiss side affirmed that the Hainan FTP’s conducive business environment and preferential policies (especially the innovative measures in the Boao Lecheng International Medical Tourism Pilot Zone) mean that the island has broad development prospects in the medical and health industry. Lecheng has become the primary rapid access channel for global innovative medical products entering China, and many Swiss medical companies—in learning about how the FTP’s preferential policies support Lecheng—are now planning to deepen cooperation with Hainan.
The conference saw contract signings take place between Sonova & the Boao Lecheng International Medical Tourism Pilot Zone, Industrie Biomediche Insubri SA & Susheng Biotech, and Dr. Dünner AG & Winhealth Pharma. Also, to promote innovative development in life sciences and the medical health industries, Switzerland Global Enterprise signed a memorandum of understanding with the Hainan Provincial Bureau of International Economic Development.


Đề xuất
Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium
InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy
3Trees Ranked No. 1 Globally by 2025 Stone Paint Sales Volume, Advancing International Strategy